Linke Medical Snares $1.4M in Pre-A Round Funding

According to yigoonet.com, Linke Medical Co., Ltd. ("Linke Medical"), located in Zhangjiang Science City, has got tens of millions of yuan (US$1.4 million) in the Pre-A round of financing, led by Shenzhen Changhe Capital Management Co. Ltd. ("Changhe Capital"). 

Linke Medical focuses on providing inhalation anesthesia products including inhalation anesthesia reagents, inhalation anesthesia drug packaging materials, anesthesia monitoring, intelligent monitoring, covering the upper, middle and downstream supply chain in the industry. Through technological innovation and resource integration, Linke Medical is committed to becoming a global provider of comprehensive solutions in the vertical market of inhaled anesthesia.

Technological upgrades and effective use of related instruments have largely affected the widespread use of inhaled anesthetics. In the United States, nearly 90 percent of surgical patients receive general anesthesia, of which inhaled anesthesia accounts for nearly 80 percent. However, the use of inhaled anesthesia in China is far less than that in the United States, and there is still much space for improvement.

At present, Linke Medical has built a professional team for R&D, registration, production, operation, and marketing. The founder of Linke Medical has more than 10 years of experience in the anesthesia field. Its team members are top experts in Shenzhen, and management and technology talents with multinational and local medical working background.

Linke Medical is looking forward to making full use of the talent resource in the field of pharmaceutical R&D in Shanghai and the medical electronics supply chain in Shenzhen (its wholly-owned subsidiary Shenzhen Colin), to achieve the collaborative development of drugs and instruments in those two cities. Through innovation and exploration in the inhalation anesthesia industry, Linke Medical hopes to become a strong force for the industrial upgrade.

Founded in 2015, Changhe capital is an investment firm focusing on entrusted asset management, equity investment, and investment management.